Inventor · disambiguated record
Richard Judson
Also filed as: JUDSON RICHARD S
5 granted patents·18 pending applications·350 citations·filing 2000–2007
84Inventor score
Top patents by PatentIndex Score
23 records- 0194US6931326B1Methods for obtaining and using haplotype dataGENAISSANCE PHARMACEUTICALS·Filed 2001·Granted Aug 16, 2005·136 cites·37 claims
- 0292US7058517B1Methods for obtaining and using haplotype dataGENAISSANCE PHARMACEUTICALS·Filed 2000·Granted Jun 6, 2006·161 cites·4 claims
- 0379US6586183B2Association of β2-adrenergic receptor haplotypes with drug responseGENAISSANCE PHARMACEUTICALS·Filed 2001·Granted Jul 1, 2003·13 cites·10 claims
- 0478US6944767B1Methods and apparatus for ensuring the privacy and security of personal medical informationGENAISSANCE PHARMACEUTICALS·Filed 2000·Granted Sep 13, 2005·34 cites·9 claims
- 0569US7250258B2CDK5 genetic markers associated with galantamine responsePGXHEALTH LLC·Filed 2004·Granted Jul 31, 2007·6 cites·26 claims
- 0652US2008166723A1CDK5 genetic markers associated with galantamine responsePGXHEALTH LLC·Filed 2007·Application pending·0 cites
- 0751US2005026117A1System and method for the management of genomic dataFiled 2001·Application pending·0 cites
- 0849US2005191731A1Methods for obtaining and using haplotype dataFiled 2001·Application pending·0 cites
- 0949US2004267458A1Methods for obtaining and using haplotype dataFiled 2001·Application pending·0 cites
- 1048US2005255495A1SLC5A7 genetic markers associated with age of onset of Alzheimer's diseaseGENAISSANCE PHARMACEUTICALS·Filed 2004·Application pending·0 cites
- 1147US2006166219A1NTRK1 genetic markers associated with progression of Alzheimer's diseaseGENAISSANCE PHARMACEUTICALS·Filed 2004·Application pending·0 cites
- 1247US2005250122A1APOA4 genetic markers associated with progression of Alzheimer's diseaseGENAISSANCE PHARMACEUTICALS·Filed 2004·Application pending·0 cites
- 1347US2005255492A1CHRNA9 genetic markers associated with progression of Alzheimer's diseaseGENAISSANCE PHARMACEUTICALS·Filed 2004·Application pending·0 cites
- 1447US2005260613A1LRPAP1 genetic markers associated with galantamineGENAISSANCE PHARMACEUTICALS·Filed 2004·Application pending·0 cites
- 1547US2005250118A1EPHX2 Genetic markers associated with galantamineGENAISSANCE PHARMACEUTICALS·Filed 2004·Application pending·0 cites
- 1647US2005250121A1NTRK2 genetic markers associated with progression of Alzheimer's diseaseGENAISSANCE PHARMACEUTICALS·Filed 2004·Application pending·0 cites
- 1747US2005255488A1NTRK1 genetic markers associated with age of onset of Alzheimer's DiseaseGENAISSANCE PHARMACEUTICALS·Filed 2004·Application pending·0 cites
- 1842US2005048543A1CHRNA2 genetic markers associated with galantamine responseFiled 2004·Application pending·0 cites
- 1942US2003091998A1Association of beta2-adrenergic receptor haplotypes with drug responseFiled 2001·Application pending·0 cites
- 2041US2003039979A1Association of beta2-adrenergic receptor haplotypes with drug responseFiled 2001·Application pending·0 cites
- 2137US2006154265A1LDLR genetic markers associated with age of onset of Alzheimer's DiseaseGENAISSANCE PHARMACEUTICALS·Filed 2005·Application pending·0 cites
- 2237US2005277129A1APOE genetic markers associated with age of onset of Alzheimer's diseaseGENAISSANCE PHARMACEUTICALS·Filed 2005·Application pending·0 cites
- 2337US2005255498A1APOC1 genetic markers associated with age of onset of Alzheimer's DiseaseGENAISSANCE PHARMACEUTICALS·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Richard Judson files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →